IOVA

Finckenstein Friedrich Graf

Known title: Chief Medical OfficerCIK: 0001782981

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 13, 2026

Iovance Biotherapeutics sees analyst target raise and whale activity. Recent reports show large investors were active in IOVA shares, indicating heightened interest. Baird kept a neutral stance but lifted its price target to $11, above its prior level. The Q2 2026 earnings call highlighted ongoing clinical progress, which aligns with the analyst’s revised outlook. The stock is near the upper end of its 52‑week range.

this person other insiders at IOVA

Transaction History

IOVA▲ Buy$0
IOVA▼ Sell$17K
IOVA▲ Buy$0
IOVA▼ Sell$18K
IOVA▲ Buy$0
IOVA▼ Sell$76K
IOVA▲ Buy$0
IOVA▼ Sell$27K
IOVA▼ Sell$4K
IOVA▲ Buy$0
IOVA▲ Buy$0
IOVA▼ Sell$10K
IOVA▲ Buy$0
IOVA▼ Sell$14K
IOVA▲ Buy$0
IOVA▼ Sell$11K
IOVA▲ Buy$0
IOVA▼ Sell$135K
IOVA▼ Sell$9K
IOVA▲ Buy$0
IOVA▲ Buy$0
IOVA▼ Sell$18K
IOVA▲ Buy$0
IOVA▼ Sell$14K
IOVA▲ Buy$0
IOVA▼ Sell$22K
IOVA▼ Sell$129K
IOVA▲ Buy$0
IOVA▲ Buy$0
IOVA▼ Sell$12K
IOVA▲ Buy$0
IOVA▼ Sell$17K
IOVA▲ Buy$0
IOVA▼ Sell$17K
IOVA▲ Buy$0
IOVA▼ Sell$137K
IOVA▲ Buy$0
IOVA▼ Sell$13K
IOVA▲ Buy$0
IOVA▼ Sell$5K
IOVA▲ Buy$0
IOVA▼ Sell$11K
IOVA▲ Buy$0
IOVA▼ Sell$8K
IOVA▲ Buy$0
IOVA▼ Sell$30K
IOVA▲ Buy$0
IOVA▼ Sell$67K
IOVA▼ Sell$53K
IOVA▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.